OLD Category: FFPE

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations☆

• Conforti F, Pala L, Pagan E...Viale G, Colleoni M, Goldhirsch A

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy

• Mukha A, Kahya U, Linge A...Krause M, Peitzsch C, Dubrovska A

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial

• Duerinck J, Schwarze JK, Awada G...Everaert H, Forsyth R, Neyns B

A Distinct Innate Immune Signature of Early Onset Colorectal Cancer

• Gardner IH, Siddharthan R, Watson K, Dewey E, Ruhl R, Khou S, Guan X, Xia Z, Tsikitis VL, Anand S

Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma

• Eviston TJ, Minaei E, Mueller SA, Ahmadi N, Ashford B, Clark JR, West N, Zhang P, Gupta R, Ranson M

Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma

• Jiang L, Chen S, Stinnett V...Gocke CD, Lin MT, Zou YS

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer

• Roper N, Velez MJ, Chiappori A, Kim YS, Wei JS, Sindiri S, Takahashi N, Mulford D, Kumar S, Ylaya K, Trindade C, Manukyan I, Brown AL, Trepel JB, Lee JM, Hewitt S, Khan J, Thomas A

Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma

• Nath K, Law SC, Sabdia MB...Trotman J, Law P, Gandhi MK

Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution

• Macerola E, Proietti A, Poma AM...Elisei R, Santini F, Basolo F

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy

• Chic N, Schettini F, Brasó-Maristany F...Pascual T, Bellet M, Prat A

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy: ER activity in pre-menopausal HR+ breast cancer during CT

• Chic N, Schettini F, Braso-Maristany F...Pascual T, Bellet M, Prat A

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

• Sánchez‐Herrero E, Serna‐Blasco R, Ivanchuk V...González‐Rumayor V, Provencio M, Romero A